Methenamine Hippurate (Carilion Materials Management)


Welcome to the PulseAid listing for the Methenamine Hippurate drug offered from Carilion Materials Management. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Methenamine Hippurate
SUBSTANCE NAME: METHENAMINE HIPPURATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-07-01
END MARKETING DATE: 0000-00-00


Methenamine Hippurate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethenamine Hippurate from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2003-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-0984_4ea002b4-0da9-40c9-b1cd-36c29b156d5f
PRODUCT NDC: 68151-0984
APPLICATION NUMBER: ANDA076411

Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Methenamine Hippurate
Aurobindo Pharma LimitedMethenamine Hippurate
Carilion Materials ManagementMethenamine Hippurate
CorePharma, LLCMethenamine Hippurate
County Line Pharmaceuticals, LLCMethenamine Hippurate
Leading Pharma, LLCMethenamine Hippurate
Sanofi-Aventis U.S. LLCHiprex
Validus Pharmaceuticals LLCHIPREX
Winthrop U.S.Methenamine Hippurate